The invention discloses an
artificial intelligence platform for comprehensive radiological
image analysis across CT, MRI, and X-
ray modalities. The
system automatically detects and quantifies cardiac, pulmonary, and oncological abnormalities through multiple AI modules including heart localization, cardiac MRI quantification, pneumonia classification, and tumor segmentation / grading. The platform provides automated
tumor detection, 3D volumetric segmentation, and
malignancy grading and treatment planning. The
system integrates
hybrid CNN-
Transformer networks, attention-based 3D segmentation, and multi-
modal feature fusion, offering precise quantitative
metrics for
tumor size, volume, shape, and
malignancy probability. It also a cardiac MRI analysis module measures atrial and ventricular volumes and detects
atrial fibrillation or
mitral valve stenosis. It calculates the cardiothoracic ratio and detects heart displacement.
DICOM / PACS integration and
federated learning enable clinical deployment and cross-institutional adaptability while preserving
patient data privacy and assists clinicians in accurate and rapid diagnosis while minimizing
human error. This first-in-world platform facilitates
early detection, staging, grading, and treatment planning with high reproducibility and explainable outputs.